Dr Ashish Khanna on the PRODIGY Trial and Risk Score

Published: March 11, 2019, 6:32 p.m.

Dr Ashish Khanna, from Wake Forest School of Medicine, discusses his research on a novel opioid-induced respiratory depression risk score, its benefits for practice, and more.